← Back
$JNJ All transactions

JOHNSON & JOHNSON

M

$ Value

$2.2M

Shares

19,241

Price

$116

Filed

Feb 18

Insider

Name

Wolk Joseph J

Title

Exec VP, CFO

CIK

0001744564

Roles

Officer

Transaction Details

Transaction Date

2026-02-17

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

58,202

Footnotes

Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. | Shares withheld for payment of taxes upon vesting of PSUs. | Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting. | Shares withheld for payment of taxes upon vesting of RSUs. | Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting. | Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2025 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. | This transaction was executed in multiple trades at prices ranging from $242.94 to $243.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $242.85 to $242.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $242.71 to $242.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $242.59 to $242.815. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | Held in a spousal lifetime access trust, of which the reporting person's spouse is the trustee and beneficiary. | Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2026). | Each RSU represents a contingent right to receive one share of Company Common Stock. | Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. | Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 15, 2026 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting on a one for one basis. | Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable one day after the third anniversary of the grant date.

Filing Info

Accession No.

0000200406-26-000041

Form Type

4

Issuer CIK

0000200406

Wolk Joseph J's History

Date Ticker Type Value
2026-03-12 PRU A $2K
2026-02-17 JNJ M $2.2M
2026-02-17 JNJ $4.7M
2026-02-17 JNJ M $1.6M
2026-02-17 JNJ $2.9M
2026-02-17 JNJ M $4.4M
2026-02-17 JNJ $8.1M
2026-02-17 JNJ $6.1M
2026-02-17 JNJ M $0
2026-02-17 JNJ M $0

Other Insiders at JNJ (90d)

Insider Bought Sold Last
REED JOHN C
EVP, Innovative Medicine, R&D
$13.1M 2026-02-17
HEWSON MARILLYN A 2026-03-10
Pinto Daniel E 2026-03-10
Duato Joaquin
CEO and Chairman of the Board
$22.1M 2026-02-15
Wolk Joseph J
Exec VP, CFO
$21.8M 2026-02-17
Taubert Jennifer L
EVP, WWC. Innovative Medicine
2026-02-15
Wengel Kathryn E
EVP, Chief TO and Risk Officer
2026-02-15
Woods Eugene A. 2026-03-10
Decker Robert J
VP Corporate Controller
$1.0M 2026-02-27
Swanson James D.
EVP, CIO
$15.1M 2026-02-17
Broadhurst Vanessa
EVP, Global Corp Affairs
$1.5M 2026-02-17
Forminard Elizabeth
EVP, Chief Legal Officer
2026-02-15
Schmid Timothy
EVP, WW Chair, MedTech
$5.9M 2026-02-20
Mulholland Kristen
EVP, Chief HR Officer
2026-02-15